Prescription Drug Wholesale Acquisition Cost (WAC) Increases
Data and Resources
-
Prescription Drugs WAC Increases - Data DictionaryCSV
-
Prescription Drugs WAC Increases - 5 Year...CSV
-
April Monthly Update - Prescription Drug WAC...XLSX
-
April Monthly Update - Prescription Drug WAC...CSV
-
April Monthly Update - Prescription Drug WAC...XLSX
-
April Monthly Update - Prescription Drug WAC...CSV
-
Q1 - Q4 2022 Prescription Drug WAC IncreasesXLSX
-
Q1 - Q4 2022 Prescription Drug WAC Increases -...XLSX
-
Q1 - Q4 2021 Prescription Drug WAC IncreasesXLSX
-
Q1 - Q4 2021 Prescription Drug WAC Increases -...XLSX
-
Q1-Q4 2020 Prescription Drugs WAC IncreasesXLSX
-
Q1-Q4 2020 Prescription Drugs WAC Increases -...XLSX
-
Q1-Q4 2019 Prescription Drugs WAC IncreasesXLSX
-
Q1-Q4 2019 Prescription Drugs WAC Increases -...XLSX
-
Diabetes NDCs WAC IncreasesXLSX
This dataset is a subset of the CTRx data presenting diabetes related...
Additional Info
Field | Value |
---|---|
Contact Email | [email protected] |
Program | Accounting and Reporting Systems Section, Information Services Division |
Homepage URL | https://hcai.ca.gov/data-and-reports/cost-transparency/rx/ |
Temporal Coverage | 2023 |
Spatial/Geographic Coverage | Statewide |
Geographic Granularity | Statewide |
Language | English |
Frequency | Monthly |
De-Identification Method | A manufacturer may limit the information reported to that which is otherwise in the public domain or publicly available. |
Data Collection Tool | |
License | Terms of Use |
Limitations | Use of this data is subject to the CHHS Terms of Use and any copyright and proprietary notices incorporated in or accompanying the individual files. |
Related Resources | |
Last Updated | April 4, 2024, 15:32 (UTC) |
Accept OPA Terms of Use
Users of this data file provided by the Office of the Patient Advocate (OPA) shall not have the right to alter, enhance, or otherwise modify the data. Anyone desiring to use or reproduce the data without modification for a noncommercial purpose may do so without obtaining approval. All commercial uses must be approved and may be subject to a license. See the data file for data source and disclaimer information. Contact the Office of the Patient Advocate for more information.